3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
8
Phase 1
4
Phase 3
2
Phase 1/2
2
Phase NA
1
Status
Completed
1
Active not recruiting
1
Sponsor Class
OTHER
1
NETWORK
1
Study Type
Interventional
2
Sponsor
Cancer Type
Sarcoma
2
Conditions
Lymphoma
35
Leukemia
34
Small Cell Lung Carcinoma
33
Leukemia, Myeloid, Acute
25
Precursor Cell Lymphoblastic Leukemia-Lymphoma
24
Lung Neoplasms
24
Lymphoma, Large B-Cell, Diffuse
19
Neuroblastoma
15
Lymphoma, Non-Hodgkin
15
Carcinoma, Non-Small-Cell Lung
14
Leukemia, Erythroblastic, Acute
13
Hodgkin Disease
13
Leukemia, Myelomonocytic, Acute
12
Leukemia, Monocytic, Acute
12
Leukemia, Megakaryoblastic, Acute
12
Sarcoma
11
Lymphoma, Follicular
10
Burkitt Lymphoma
10
Lymphoma, Large-Cell, Immunoblastic
9
Testicular Neoplasms
7
Teratoma
7
Myelodysplastic Syndromes
7
Congenital Abnormalities
7
Multiple Myeloma
6
Endodermal Sinus Tumor
6
Anemia, Refractory, with Excess of Blasts
6
Testicular Germ Cell Tumor
5
Ovarian Neoplasms
5
Neuroectodermal Tumors, Primitive, Peripheral
5
Central Nervous System Neoplasms
5
Interventions
Methotrexate
4
Doxorubicin
3
Ifosfamide
2
Etoposide
2
Cisplatin
2
sodium thiosulfate
1
peginterferon alfa-2b
1
merphos
1
Zoledronic Acid
1
Triptorelin Pamoate
1
Tranexamic Acid
1
Thoracotomy
1
Thoracostomy
1
Thoracoscopy
1
Specimen Handling
1
Sodium Chloride
1
Restraint, Physical
1
Platinum
1
IMVP-16 protocol
1
Granulocyte Colony-Stimulating Factor
1
Fluoridation
1
Filgrastim
1
Fentanyl
1
Docetaxel
1
Cyproheptadine
1
1,2-diaminocyclohexaneplatinum II citrate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 3
×
Osteosarcoma
×
Etoposide
×
Clear all
NCT00470223
2025-06-08
OS2006
UNICANCER
Phase 3
Active not recruiting
318 enrolled
NCT00134030
2023-06-07
EURAMOS-1
Children's Oncology Group
Phase 3
Completed
1,334 enrolled
17 charts